SecBot SecBot
8-K ·Filed May 5, 2026

VCYT

VERACYTE, INC.
BULLISH
Impact 8/10
Horizondays Processed6mo ago SEC0001384101-26-000029
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

Strong beat and raised guidance confirm accelerating organic growth and operating leverage. Upcoming Prosigna LDT and TrueMRD launches could extend the growth trajectory. Expect positive price action at open; watch for sell-side estimate upgrades and potential analyst day catalysts.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$41.19
T+0 close · May 5, 2026 · via day close
Latest settled
+12.45%
T+60 · $46.32
Vs SPY
+10.39%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 6 $41.19entry
  2. T+1 · 6mo ago −1.04%α −0.71% · $40.76
  3. T+5 · 6mo ago −3.96%α −5.09% · $39.56
  4. T+20 · 6mo ago +18.21%α +15.43% · $48.69
  5. T+60 · 4mo ago +12.45%α +10.39% · $46.32

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Veracyte reported Q1 2026 earnings with total revenue of $139.1M (+21% YoY) and GAAP diluted EPS of $0.35, significantly beating Street consensus of $0.23. The company raised full-year 2026 total revenue guidance to $582M-$592M (from $570M-$582M) and adjusted EBITDA margin to >26% (from ~25%), driven by strong Decipher and Afirma testing volume growth.

Key Financial Metrics

EPS
$0.35
est $0.23 · +52.2%
Revenue
$139.1M
+21.0% YoY
Rating
strong beat
Guidance
$582M-$592M
raised
Free Cash Flow
$32.3M
Gross Margin
72.7%

Key Facts

  • Total revenue $139.1M, +21% YoY
  • Testing revenue $135.1M, +26% YoY
  • GAAP diluted EPS $0.35 vs Street consensus $0.23 (52% beat)
  • Decipher revenue +30% to $86.5M, Afirma revenue +21% to $46.4M
  • Raised 2026 total revenue guidance to $582M-$592M (13-14% growth)
  • Raised 2026 adjusted EBITDA margin guidance to >26%
  • Adjusted EBITDA $42.8M (30.8% margin), +73% YoY
  • Operating cash flow $35.2M, FCF $32.3M
  • Cash & investments $439.1M at quarter end

Financial Impact

EPS beat of $0.12 (+52%) and guidance raise of $12M at midpoint

revenueepsguidancemarginscash flow

Risk Factors

  • Execution risk on new product launches (Prosigna LDT, TrueMRD)
  • Reimbursement changes for molecular diagnostic tests
  • Dependence on Decipher and Afirma growth sustainability
  • Biopharmaceutical revenue decline due to Veracyte SAS restructuring

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
84% bullish (19 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001384101-26-000029
Document: vcyt-20260505.htm0001384101-26-000029
Document: 0001384101-26-000029-index-headers.html0001384101-26-000029
Document: 0001384101-26-000029-index.html0001384101-26-000029
Document: 0001384101-26-000029.txt0001384101-26-000029
8-K Data (Synthetic)0001384101-26-000029

Track record

22 reports on VCYT

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +20.37% at T+20 after the Jun 11, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $24.63 Now $24.01 −2.52% settles Dec 11
  2. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $24.00 Now $24.01 +0.04% settles Dec 4
  3. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $24.00 Now $24.01 +0.04% settles Dec 4
  4. Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $50.01 Now $24.01 −51.99% settles Nov 30
  5. Oct 28, 202619d ago Insider Cluster Neutral 2/10 Entry $52.17 Now $24.01 −53.98% settles Nov 27
  6. Oct 28, 202619d ago Insider Cluster Neutral 3/10 Entry $52.17 Now $24.01 −53.98% settles Nov 27
  7. Oct 27, 202620d ago 144 Neutral 2/10 Entry $50.31 Now $24.01 −52.28% settles Nov 25
  8. Oct 27, 202620d ago 144 Neutral 2/10 Entry $50.31 Now $24.01 −52.28% settles Nov 25
  9. Sep 22, 20267w ago Insider Cluster Neutral 2/10 Entry $43.82 to $46.22 Now $24.01 −45.21% ▲ +5.48% +4.79% vs SPY
  10. Sep 14, 20269w ago Press Release Bullish 6/10 Entry $40.14 to $43.11 Now $24.01 −40.18% ▲ +7.40% +4.68% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens Wed (10h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026